| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Academic Drug Discovery Units in the UK: Progress and challenges
|
Hopkins, Michael M.
|
|
|
30 |
1 |
p.
|
artikel
|
| 2 |
Breakthrough in RAS targeting with pan-RAS(ON) inhibitors RMC-7977 and RMC-6236
|
Filis, Panagiotis
|
|
|
30 |
1 |
p.
|
artikel
|
| 3 |
Corrigendum to “A review of in vitro and in vivo methods and their correlations to assess mouthfeel of solid oral dosage forms” [Drug Discov. Today 26(3) (2021) 740–753]
|
Asiri, Abdullah
|
|
|
30 |
1 |
p.
|
artikel
|
| 4 |
3D molecular generation models expand chemical space exploration in drug design
|
Xiang, Yu-Ting
|
|
|
30 |
1 |
p.
|
artikel
|
| 5 |
Exploration of small-molecule inhibitors targeting Hsp110 as novel therapeutics
|
Zhao, Rui
|
|
|
30 |
1 |
p.
|
artikel
|
| 6 |
Four years after the ranitidine withdrawal by FDA: Is it time for India to act?
|
Ezhilarasan, Devaraj
|
|
|
30 |
1 |
p.
|
artikel
|
| 7 |
Generative AI: driving productivity and scientific breakthroughs in pharmaceutical R&D
|
Doron, Guy
|
|
|
30 |
1 |
p.
|
artikel
|
| 8 |
‘Home inspections’ for life sciences companies going public before clinical proof-of-concept
|
Bespalov, Anton
|
|
|
30 |
1 |
p.
|
artikel
|
| 9 |
How can MSI enhance our understanding of ASO distribution?
|
van der Vloet, Laura
|
|
|
30 |
1 |
p.
|
artikel
|
| 10 |
IdopNetwork as a genomic predictor of drug response
|
Che, Jincan
|
|
|
30 |
1 |
p.
|
artikel
|
| 11 |
Learning from European regulator-initiated studies for regulatory decision making
|
Verweij, Stefan
|
|
|
30 |
1 |
p.
|
artikel
|
| 12 |
Magnetic microscale polymeric nanocomposites in drug delivery: advances and challenges
|
Shi, Kejing
|
|
|
30 |
1 |
p.
|
artikel
|
| 13 |
Neuropsychiatric drug development: Perspectives on the current landscape, opportunities and potential future directions
|
Loiodice, Simon
|
|
|
30 |
1 |
p.
|
artikel
|
| 14 |
Nondestructive techniques for pharmaceutical drug product characterization
|
Beg, Sarwar
|
|
|
30 |
1 |
p.
|
artikel
|
| 15 |
Novel therapeutic targets for cardiorenal syndrome
|
Trivedi, Mansi Vinodkumar
|
|
|
30 |
1 |
p.
|
artikel
|
| 16 |
Oleuropein: a viable therapeutic option for malaria and cancer
|
Devi, Sonia
|
|
|
30 |
1 |
p.
|
artikel
|
| 17 |
Redefining what it means to age – the impact to society and pharmaceutical industry
|
Jones, Charles H.
|
|
|
30 |
1 |
p.
|
artikel
|
| 18 |
Repairing muscle with broccoli-derived sulforaphane: A preclinical evaluation for the treatment of mitochondrial myopathies
|
Lilley, Thomas
|
|
|
30 |
1 |
p.
|
artikel
|
| 19 |
Revising EU pharmaceutical legislation: will it foster drug repurposing?
|
Scholte, Mirre
|
|
|
30 |
1 |
p.
|
artikel
|
| 20 |
Salt-inducible kinases (SIKs) in cancer: mechanisms of action and therapeutic prospects
|
Manoharan, Ravi
|
|
|
30 |
1 |
p.
|
artikel
|
| 21 |
Speed of innovation: How quickly are different therapeutic areas adopting paradigm-shifting drugs?
|
Gutzeit, Vanessa A.
|
|
|
30 |
1 |
p.
|
artikel
|
| 22 |
Stimulating development of innovative medicines in the European Union: does a new definition for unmet medical need add value?
|
Bloem, Lourens T.
|
|
|
30 |
1 |
p.
|
artikel
|
| 23 |
Targeting spleen tyrosine kinase (SYK): structure, mechanisms and drug discovery
|
Zhang, Shuangqian
|
|
|
30 |
1 |
p.
|
artikel
|
Tijdschrift beschrijving